Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
MasterCard
MA
5
American Express
AXP
JP Stock MarketDetailed Quotes
197A Tauns Laboratories
- 502
- -3-0.59%
20min DelayMarket Closed May 2 15:30 JST
51.40BMarket Cap9.30P/E (Static)
510High500Low413.10KVolume508Open505Pre Close208.22MTurnover73352wk High1.78%Turnover Ratio102.39MShares40152wk Low53.99EPS TTM11.67BFloat Cap733Historical High9.30P/E (Static)23.25MShs Float401Historical Low53.99EPS LYR1.98%Amplitude11.00Dividend TTM3.15P/B100Lot Size2.12%Div YieldTTM
Tauns Laboratories News
Tauns Laboratories: TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests fo
Tauns Laboratories: Towns Co., Ltd. signed a capital and business partnership agreement with CraiF Co., Ltd., a startup that performs early cancer detection tests using urinary microRNA
Tauns Laboratories: Notice of Capital and Business Alliance with Aillis, Inc. and Acquisition of Shares through Third-Party Allocation of New Shares.
Tauns Laboratories: Notice regarding capital and business alliance with Iris Co., Ltd. and acquisition of the company's shares through third-party allotment of shares
Tauns Laboratories: Change report.
Tauns Laboratories: TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes
Tauns Laboratories: A capital and business alliance agreement was concluded with KINS Co., Ltd., a healthcare startup specializing in Towns Microbiome Co., Ltd.
Tauns Laboratories: Financial Highlights for 2Q ended December 31, 2024
Tauns Laboratories: Interim financial results presentation materials for the fiscal year ending 2025/6
Tauns Laboratories: Financial Results for the SIX Months Ended December 31, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)
Tauns Laboratories: Half Year Report - Term 10 (2024/07/01 - 2025/06/30)
Tauns Laboratories: Confirmation
Tauns Laboratories: Notice of Strategic Business Alliance with ZACROS Corporation
Tauns Laboratories: Announcement of a strategic business alliance with ZACROS Co., Ltd.
Tauns Laboratories: Patent on Method and Reagent for Detecting Target Substance Granted in Japan
Tauns Laboratories: Notice of patent acquisition relating to target substance detection methods and reagents
Tauns Laboratories: (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
Tauns Laboratories: (Progress of disclosure matters) Notice of conclusion of a basic transaction agreement with Roche Diagnostics Co., Ltd.
Tauns Laboratories: Correction report (Large shareholding report / Change report)
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting